Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

WILLIAM'S HEMATOLOGY > 131 Hereditary Thrombophilia > Flashcards

131 Hereditary Thrombophilia Flashcards

1
Q

Examples of acquired thrombophilia

A

Antiphospholipid syndrome, cancer, surgery, strict immobilization, pregnancy and the postpartum period, and the use of estrogen-containing medication, such as oral contraceptives and hormone replacement therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

TRUE OR FALSE

Hereditary thrombophilia has mean age at time of a first thrombosis being approximately 10 years lower than in the general population, the majority of patients with thrombophilia have the first episode later in life.

A

TRUE

Hereditary thrombophilia has mean age at time of a first thrombosis being approximately 10 years lower than in the general population, the majority of patients with thrombophilia have the first episode later in life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TRUE OR FALSE

Hereditary thrombophilia is a major risk factor for arterial cardiovascular disease.

A

FALSE

Hereditary thrombophilia is not a major risk factor for arterial cardiovascular disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

TRUE OR FALSE

Most hereditary thrombophilias are also modestly associated with pregnancy-related disorders

A

TRUE

Most hereditary thrombophilias are also modestly associated with pregnancy-related disorders

Such as recurrent miscarriage; stillbirth; intrauterine growth retardation; preeclampsia; and the hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome of pregnancy, although for later pregnancy complications, this association is controversial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The genetic basis for activated protein C (APC) resistance

A

Single point mutation in the factor V gene
Factor V Leiden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Common Hereditary Thrombophilia among the general population

A

Elevated FVIII:c levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Common Hereditary Thrombophilia among Patients with VTE

A

Elevated FVIII:c levels (25%)
Factor V Leiden (21%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Types of antithrombin and protein C deficiency

A
  • Type I: both antigen and activity are reduced
  • Type II: antigen levels are normal, but one or more functional defects in the molecule lead to a decreased activity
  • Type IIa: defect is located in the thrombin binding domain (ie, the reactive site)
  • Type IIb: defect is located in the heparin binding domain
  • Type IIc: pleiotropic group of mutations

Interestingly, patients with type IIb deficiency seem to have a significantly lower risk of VTE than other types.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Two forms of protein S

A
  • Free protein S (∼40–50%): functions as a cofactor for APC
  • Protein S bound to complement component C4b-binding protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Types of Protein S deficiency

A
  • Type I deficiency: total and free antigen levels and activity are all reduced
  • Type II deficiency: total and free antigen are normal, but activity is reduced
  • Type III deficiency: activity and free antigen are reduced, but total antigen is low to normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TRUE OR FALSE

Most laboratory panels now only test the activity of antithrombin, protein C, or protein S and thereby do not distinguish between different types of deficiencies.

A

TRUE

Most laboratory panels now only test the activity of antithrombin, protein C, or protein S and thereby do not distinguish between different types of deficiencies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

TRUE OR FALSE

Homozygous type I deficiency has never been described in humans and is believed to be incompatible with life.

A

TRUE

Homozygous type I deficiency has never been described in humans and is believed to be incompatible with life.

Homozygous protein C and protein S deficiencies are also very rare and are associated with neonatal purpura fulminans and massive thrombosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In the general population, the prevalence of the deficiencies of the natural anticoagulants combined is approximately ____%

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The most common hereditary thrombophilia

A

Factor V Leiden mutation

Factor V Leiden is very rare among Asians and Africans but has a high prevalence (∼5%) among whites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Underlying genetic defect in Factor V Leiden disease

A

Single G-to-A substitution in the gene of factor V at nucleotide position 1691

Resulting in an amino acid change from arginine (Arg) to glutamine (Gln) at position 506, the first cleavage site of factor Va for APC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The high prevalence of factor V Leiden suggests an evolutionary benefit such as:

A
  • Reduced peripartum and menstrual blood loss in affected female carriers
  • Increased sperm counts and a shorter conception time in affected male and female carriers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

TRUE OR FALSE

Unlike factor V Leiden, the prothrombin G20210A mutation is found largely in Asians.

A

FALSE

Like factor V Leiden, the prothrombin G20210A mutation is found largely in white.

18
Q

____________ is the most common familial, albeit not monogenetic, thrombophilia with an estimated population attributable risk of 15%

A

Increased level of FVIII

19
Q

Most of coagulation FVIII circulates in complex with

A

vWF

20
Q

Conditions/factors have been associated with high FVIII levels

A

Increasing age, high body mass index, diabetes mellitus, and hypertriglyceridemia

High FVIII levels are part of acute-phase reactions and sustained increases are observed during pregnancy, surgery, chronic inflammation, malignancy, liver disease, hyperthyroidism, renal disease.

21
Q

TRUE OR FALSE

Increased FVIII levels in patients with VTE are usually not influenced by acute-phase reactions.

A

TRUE

Increased FVIII levels in patients with VTE are usually not influenced by acute-phase reactions

The association between high FVIII levels and venous thrombosis is well established.

22
Q

Tests not affected by various factors during testing

Examples

  • Use of VKAs, which reduces the levels of anticoagulant factors protein C and protein S
  • Pregnancy: reduces free protein S levels and increases APC resistance and FVIII levels
A

Factor V Leiden
Prothrombin G20210A

23
Q

Enzymes involved in homocysteine metabolism are dependent on what vitamins

A

Vitamin B6, folic acid, and vitamin B12

Deficiencies lead to hyperhomocysteinemia

24
Q

Common genetic cause of mild hyperhomocysteinemia

A

Polymorphism in the enzyme methylenetetrahydrofolate reductase (MTHFR), c.C677T

Leads to an alanine to valine substitution at position 222 resulting in a variant enzyme with reduced activity and increased thermolability

The prevalence is 10% to 20% in whites and 10% in Asians, but it is rare in Africans.

25
Q

Other conditions are associated with hyperhomocysteinemia

A

Renal failure, hypothyroidism, smoking, excessive coffee consumption, inflammatory bowel disease, psoriasis, and rheumatoid arthritis

26
Q

Severe hyperhomocysteinemia (plasma levels >100 μmol/L)

A rare autosomal recessive disorder clearly associated with vascular occlusive disease

A

Homocystinuria

27
Q

TRUE OR FALSE

Homocysteine lowering by B vitamins reduce the incidence of recurrent events both in patients with VTE as well as in patients with arterial cardiovascular disease

A

FALSE

Homocysteine lowering by B vitamins did not reduce the incidence of recurrent events both in patients with VTE as well as in patients with arterial cardiovascular disease

As a result of these studies, homocysteine testing (either its levels of polymorphisms) as part of a thrombophilia panel has been largely abandoned.

28
Q

TRUE OR FALSE

For deficiencies of the natural anticoagulants as well as for elevated FVIII levels, repeated testing should be performed to exclude spuriously abnormal tests.

A

TRUE

For deficiencies of the natural anticoagulants as well as for elevated FVIII levels, repeated testing should be performed to exclude spuriously abnormal tests.

Most known is the use of VKAs, which reduces the levels of anticoagulant factors protein C and protein S, which can thereby mimic severe deficiencies.

Another example is pregnancy, which reduces free protein S levels and increases APC resistance and FVIII levels.

29
Q

TRUE OR FALSE

Genetic testing for deficiencies of the natural anticoagulants is not performed because of the large number of known mutations.

A

TRUE

Genetic testing for deficiencies of the natural anticoagulants is not performed because of the large number of known mutations.

30
Q

TRUE OR FALSE

Individuals heterozygotes for the prothrombin G20210A or factor V Leiden mutations are at higher risk for VTE than homozygous.

A

FALSE

Individuals homozygous for the prothrombin G20210A or factor V Leiden mutations are at higher risk for VTE than heterozygotes.

Likewise, patients with combined thrombophilic disorders have a higher risk of VTE than those with a single defect.

31
Q

Hereditary thrombophilia no association/no consistent association with arterial thrombosis

A
  • Antithrombin deficiency
  • Protein C deficiency
  • Protein S deficiency
32
Q

TRUE OR FALSE

Regardless of thrombophilia, the absolute risk of a recurrent episode is much higher than the risk of a first episode of VTE.

A

TRUE

Regardless of thrombophilia, the absolute risk of a recurrent episode is much higher than the risk of a first episode of VTE.

33
Q

The most important determinant of recurrence is the

A

Presence of transient clinical risk factors during the time of the first episode

34
Q

After an unprovoked first episode of VTE, the risk of recurrence is approximately ___% in the first year after cessation of anticoagulation and approximately ___% per year thereafter.

A

10%

5%

35
Q

Other determinants for recurrence of VTE

A
  • Male sex
  • Proximal (vs distal) DVT
  • Elevated D-dimer levels after stopping anticoagulation
36
Q

GENERAL CONSIDERATIONS OF THROMBOPHILIA TESTING

A
  • First, an obvious disadvantage of testing for thrombophilia is the high cost.
  • Second, although the psychological impact and consequences of knowing that one is a carrier of a (genetic) thrombophilic defect are considered limited, a qualitative study described several negative effects of both psychological and social origins.
  • Third, the most compelling argument against testing is the potential false reassurance that may arise from a negative thrombophilia test for individuals who come from families with a thrombotic tendency.
37
Q

The 2018 American Society of Hematology guidelines recommends postpartum thrombosis prophylaxis in women with:

A
  • Antithrombin
  • Protein C, or protein S deficiency
  • Family history of VTE
38
Q

The 2018 American Society of Hematology guidelines recommends antepartum and postpartum prophylaxis in women with:

A
  • Antithrombin deficiency and a family history of VTE
  • Homozygous for factor V Leiden or prothrombin mutation
  • Those who have combined thrombophilias
39
Q

Thrombophilia testing is most often considered in patients with VTE, particularly if

A
  • Young
  • Recurrent episodes
  • Thrombosis at unusual sites
  • Positive family history for the disease
40
Q

TRUE OR FALSE

The association between hereditary thrombophilia and arterial cardiovascular disease is questionable or at least much weaker than for VTE.

A

TRUE

The association between hereditary thrombophilia and arterial cardiovascular disease is questionable or at least much weaker than for VTE.

The association is stronger in patients with events before the age of 55 years.

41
Q

Thrombophilia testing in asymptomatic relatives may be useful in

A
  • Families with antithrombin, protein C, or protein S deficiency or
  • For siblings of patients who are homozygous for factor V Leiden and is limited to women who intend to become pregnant or who would like to use oral contraceptives

Still, testing for thrombophilia serves only a limited purpose and should not be performed on a routine basis.

WILLIAM'S HEMATOLOGY (109 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions